Skip to content

Treatment Of Hypertension By Marma Therapy

Anatomical Study OF Talhridaya Marma W.S.R.To Therapeutic Effect Of Marma Therapy In Raktagata Vata

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/046941
Enrollment
50
Registered
2022-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

MADAN MOHAN MALVIYA GOVERNMENT AYURVEDA COLLEGE UDAIPUR RAJSTHAN
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Person who will be ready to sign consent form. 2.Person having symptoms of RAKTAGATAVATA.

Exclusion criteria

Exclusion criteria: 1.Person below the age of 18 years and above the age of 70 years. 2.Person having congenital structural deformities. Any previous surgical history less than 6 months to 3.1 year related to the site this marma. Patient suffering from cardiac disorders.

Design outcomes

Primary

MeasureTime frame
Symptomatic Relief in Raktagata Vata By Marma TherapyTimepoint: 4 weeks to 8 weeks

Secondary

MeasureTime frame
Hypertension ControlTimepoint: 4 Weeks to 12 Weeks

Countries

India

Contacts

Public ContactProf Jitendra Kumar Sharma

Madan Mohan Malviya Government Ayurveda College Udaipur Rajsthan

jk2009sharma@gmail.com9784988488

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026